


Selected Abstracts from the EASL
Conference – April 14-18, 2004 Berlin, German
Hepatitis C
HCV Treatment
Acute Hepatitis C
- Interferon based therapies
Current Therapies-
- Interferon based therapies
- Pegasys
- Peg-Intron
- Conventional interferon
Diagnostic Tools –
Disease Progression–
Epidemiology
Experimental Therapies–
- Interferon based therapies
- Merimepodib (VX-497)
- NM 238
Genotype–
Predicting Treatment Response–
- Interferon based therapies
Quality of Life–
Retreatment–
Special Populations–
- Extrahepatic Manifestations
- Cryoglobulinemia Vasculitis
- Patients with Normal ALT’s
- Pediatric
- Pegasys and Special Populations
- Treatment for Non-responders / Relapsers to Previous Therapies
Transmission–
Transplantation–
- Interferon based therapies
- Interferon Alpha + Ribavirin
- Peg-Intron
Viral Kinetics–
- Interferon based therapies
Weight-Based Dosing–
- Interferon based therapies
HIV/HCV Coinfection
Current Therapies-
- Interferon based therapies
Experimental Therapies–
- Interferon based therapies
Transplantation–